A Polymorphic -844t/C in FasL Promoter Predicts Survival and Relapse in Non-Small Cell Lung Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Temporal Trends in Non-Small Cell Lung Cancer Survival in Sweden

British Journal of Cancer
Cancer ResearchOncology
2007English

FasL Gene -844t/C Mutation of Esophageal Cancer in South China and Its Clinical Significance

Scientific Reports
Multidisciplinary
2014English

Survival, Classifications, and Desmosomal Plaque Genes in Non-Small Cell Lung Cancer

International Journal of Medical Sciences
Medicine
2013English

Sphingosine Kinase‑1 Predicts Overall Survival Outcomes in Non‑small Cell Lung Cancer Patients Treated With Carboplatin and Navelbine

Oncology Letters
Cancer ResearchOncology
2019English

FSTL1 Suppresses Tumor Cell Proliferation, Invasion and Survival in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy